Finance

Beta
Lists
ELV:VIE
Elevance Health Inc
€338.20
-0.82%
(-2.80) 1D
Jun 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ELV...
Open
€334.40
High
€338.20
Low
€334.00
Mkt. cap
84.48B
Avg. vol.
10.00
Volume
0.00
52-wk high
€349.20
52-wk low
€237.00
No. of employees
97K
Open
€334.40
High
€338.20
Low
€334.00
Mkt. cap
84.48B
Avg. vol.
10.00
Volume
0.00
52-wk high
€349.20
52-wk low
€237.00
No. of employees
97K
News stories
From sources across the web
Profile
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
About Elevance Health Inc
CEOGail Koziara Boudreaux
Employees96.6K
Founded1944
HeadquartersIndianapolis, Indiana, United States
SectorHealth care provider
Websiteelevancehealth.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
49.78B
50.71B
49.75B
50.18B
Cost of goods sold
36.71B
38.14B
38.06B
35.62B
Cost of revenue
36.71B
38.14B
38.06B
35.62B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.29B
10.65B
10.75B
11.79B
Operating expense
10.44B
10.81B
10.92B
11.90B
Total operating expenses
47.14B
48.95B
48.98B
47.52B
Operating income
2.63B
1.76B
766.00M
2.66B
Other non operating income
-
-
-
-
EBT including unusual items
2.29B
1.41B
215.00M
2.30B
EBT excluding unusual items
2.29B
1.41B
399.00M
2.30B
Income tax expense
548.00M
219.00M
-331.00M
544.00M
Effective tax rate
23.91%
15.58%
-153.95%
23.61%
Other operating expenses
-
-
-
-
Net income
1.74B
1.19B
547.00M
1.76B
Net profit margin
3.50%
2.34%
1.10%
3.52%
Earnings per share
8.84
6.03
3.33
12.58
Interest and investment income
-
-
-
-
Interest expense
-341.00M
-351.00M
-367.00M
-357.00M
Net interest expenses
-341.00M
-351.00M
-367.00M
-357.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.01B
2.14B
1.17B
3.02B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer